UNIVERSAL BIOSENSORS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.145 AUD | -3.33% |
|
-3.33% | -27.50% |
| May. 30 | Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call | |
| May. 08 | Universal Biosensors Raises AU$10 Million via Entitlement Offer | MT |
Presenter SpeechCraig Coleman (Executives)Good morning, everybody. My name is Craig Coleman, a...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, womenâs health and fertility, non-human and environmental testing using its platform technology and hand-held point-of-use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates an electrochemical sensing system using opposing electrodes that detect specific analytes in samples as small as a droplet. Its products include Sentia Wine Analyzer, Xprecia Prime Coagulation Analyzer, Hemostasis Reference Laboratory (HRL) and PETRACKR Veterinary Blood Glucose Monitoring System. HRL supports contract research organizations, central laboratories, early phase clinics, pharmaceutical/ biotechnology companies and academic researchers conducting clinical trials. HRL offers multiplex cytokine analysis on the MESO QuickPlex SQ 120MM technology platform.
Calendar
2024-07-25
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -27.50% | 30.27M | |
| +2.24% | 207B | |
| +6.45% | 182B | |
| +31.46% | 157B | |
| +33.00% | 113B | |
| +4.37% | 66.91B | |
| +21.77% | 55.95B | |
| -2.92% | 47.01B | |
| -5.91% | 38.17B | |
| +3.39% | 36.49B |
- Stock Market
- Equities
- UBI Stock
- News Universal Biosensors, Inc.
- Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call
